Moseley, Brian http://orcid.org/0000-0001-8573-7340
Bourikas, Dimitrios
Dimova, Svetlana
Elmoufti, Sami
Borghs, Simon
Funding for this research was provided by:
UCB Pharma
Article History
Received: 30 November 2023
Accepted: 18 January 2024
First Online: 15 February 2024
Declarations
:
: Brian Moseley, Dimitrios Bourikas, Svetlana Dimova, Sami Elmoufti, and Simon Borghs are salaried employees of UCB Pharma and receive stock or stock options from their employment. Prior to becoming a salaried employee at UCB Pharma, Brian Moseley had previously received honoraria for serving on speaker’s bureaus and advisory boards for UCB Pharma.
: These trials on which the post-hoc analyses are based were conducted in accordance with the International Conference on Harmonisation notes for Guidance on Good Clinical Practice and the Declaration of Helsinki. The trial protocols were approved by institutional review boards at all trial sites, and written informed consent was obtained from all patients before enrollment.